A 2-year-old girl is found to have a mass in her distal extremity. Biopsy confirms infantile fibrosarcoma, and molecular testing reveals a t(12;15)(p13;q25) translocation. Given this specific molecular finding, which of the following therapeutic approaches should be considered as a first-line therapy?